The kit costs $119, requires users to be evaluated as suitable and complete a questionnaire on LabCorp’s website, LabCorp said.
Reuters reports that the United States has been trying to improve its testing capabilities, but that expansion has been hampered by a lack of professionals and personal protective equipment to ensure safety.
Collecting samples at home will reduce the risk of transmitting the virus to health workers, but there may be drawbacks, such as whether the tester has correctly collected the samples and sent them safely to the lab.
The FDA said it has worked with LabCorp to ensure that the data in its sample collection kit is safe and accurate, as it is in hospitals or other testing facilities.
Post time: May-27-2022